You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仟源醫藥(300254.SZ)獲得政府補助510萬元
格隆匯 11-22 18:04

格隆匯11月22日丨仟源醫藥(300254.SZ)公佈,公司於2019年5月27日、2019年6月10日分別收到山西省工業和信息化廳下發的《關於申報2019年山西省技術改造專項資金技術創新提升專項的通知》及大同市工業和信息化局下發的《關於組織申報仿製藥質量和療效一致性評價獎勵資金的通知》(同工信醫藥與消費品字[2019]2號)。根據上述通知內容公司分別獲得“創新能力培育—研發費用税前加計扣除獎勵”資金135萬元,“鹽酸氨溴索分散片、鹽酸氟西汀膠囊、磷黴素氨丁三醇散質量和療效一致性評價獎勵”資金合計375萬元。截止公告日,此次收到政府補助金額合計510萬元。公司目前已收到上述政府補助資金,此次政府補助與公司日常經營活動相關,以後年度是否持續發生具有不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account